Comparison of recombinant transforming growth factor-beta-2 and placebo as an adjunctive agent for macular hole surgery
Open Access
- 1 April 1998
- journal article
- clinical trial
- Published by Elsevier BV in Ophthalmology
- Vol. 105 (4), 700-706
- https://doi.org/10.1016/s0161-6420(98)94027-1
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Results of Surgical Treatment of Recent-Onset Full-Thickness Idiopathic Macular HolesAmerican Journal of Ophthalmology, 1994
- Clinicopathologic Correlation of a Macular Hole Treated by Cortical Vitreous Peeling and Gas TamponadeOphthalmology, 1994
- Pars Plana Vitrectomy for Treatment of Stage 2 Macular HolesAmerican Journal of Ophthalmology, 1994
- Vitreous Surgery for Macular HolesOphthalmology, 1993
- Stage III macular hole surgery.British Journal of Ophthalmology, 1993
- Resolution of an Absolute Scotoma and Improvement of Relative Scotomata After Successful Macular Hole SurgeryAmerican Journal of Ophthalmology, 1993
- The Effect of Pars Plana Vitrectomy and Transforming Growth Factor-Beta 2 without Epiretinal Membrane Peeling on Full-thickness Macular HolesOphthalmology, 1993
- Transforming Growth Factor-β2 for the Treatment of Full-thickness Macular HolesOphthalmology, 1992
- CLINICOPATHOLOGIC STUDY OF BILATERAL MACULAR HOLES TREATED WITH PARS PLANA VITRECTOMY AND GAS TAMPONADERetina, 1992
- Vitreous Surgery for Idiopathic Macular HolesAmerican Journal of Ophthalmology, 1991